273 related articles for article (PubMed ID: 30904930)
1. Treatment of nephrotic syndrome: going beyond immunosuppressive therapy.
Zhao J; Liu Z
Pediatr Nephrol; 2020 Apr; 35(4):569-579. PubMed ID: 30904930
[TBL] [Abstract][Full Text] [Related]
2. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
[TBL] [Abstract][Full Text] [Related]
3. [Role of podocyte injury signaling pathway in steroid-resistant nephrotic syndrome and research progress in traditional Chinese medicine intervention].
Yu WX; Yan W; Dai EL; Tian WX; Dang WJ
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3246-3254. PubMed ID: 37382008
[TBL] [Abstract][Full Text] [Related]
4. Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review.
Shah SR; Altaf A; Arshad MH; Mari A; Noorani S; Saeed E; Mevawalla AA; Haq ZU; Faquih ME
Glob J Health Sci; 2015 Aug; 8(4):136-41. PubMed ID: 26573045
[TBL] [Abstract][Full Text] [Related]
5. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical Association
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):483-7. PubMed ID: 25224050
[TBL] [Abstract][Full Text] [Related]
6. Lessons from genetics: is it time to revise the therapeutic approach to children with steroid-resistant nephrotic syndrome?
Becherucci F; Mazzinghi B; Provenzano A; Murer L; Giglio S; Romagnani P
J Nephrol; 2016 Aug; 29(4):543-50. PubMed ID: 27209298
[TBL] [Abstract][Full Text] [Related]
7. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
[TBL] [Abstract][Full Text] [Related]
8. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
[TBL] [Abstract][Full Text] [Related]
9. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.
Kemper MJ; Valentin L; van Husen M
Pediatr Nephrol; 2018 Oct; 33(10):1641-1649. PubMed ID: 28879428
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
11. Treatment of steroid resistant nephrotic syndrome in children.
Kari JA; Halawani M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
[TBL] [Abstract][Full Text] [Related]
12. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
[TBL] [Abstract][Full Text] [Related]
13. Nephrotic syndrome: Genetic testing in steroid-resistant nephrotic syndrome.
Gubler MC
Nat Rev Nephrol; 2011 Jun; 7(8):430-1. PubMed ID: 21691316
[No Abstract] [Full Text] [Related]
14. Urinary Sediment mRNA Level of CREBBP and CYBA in Children With Steroid-Resistant Nephrotic Syndrome.
Li W; Shou X; Xiang W; He L; Li L; Fu H; Mao J
Front Immunol; 2021; 12():801313. PubMed ID: 35173708
[TBL] [Abstract][Full Text] [Related]
15. Hiding in plain sight: genetics of childhood steroid-resistant nephrotic syndrome in Sub-Saharan Africa.
Williams AE; Esezobor CI; Lane BM; Gbadegesin RA
Pediatr Nephrol; 2023 Jul; 38(7):2003-2012. PubMed ID: 36459247
[TBL] [Abstract][Full Text] [Related]
16. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
Suvanto M; Patrakka J; Jahnukainen T; Sjöström PM; Nuutinen M; Arikoski P; Kataja J; Kestilä M; Jalanko H
Clin Exp Nephrol; 2017 Aug; 21(4):677-684. PubMed ID: 27573339
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid treatment exacerbates nephrotic syndrome in a zebrafish model of magi2a knockout.
Jobst-Schwan T; Hoogstraten CA; Kolvenbach CM; Schmidt JM; Kolb A; Eddy K; Schneider R; Ashraf S; Widmeier E; Majmundar AJ; Hildebrandt F
Kidney Int; 2019 May; 95(5):1079-1090. PubMed ID: 31010479
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
Preston R; Stuart HM; Lennon R
Pediatr Nephrol; 2019 Feb; 34(2):195-210. PubMed ID: 29181713
[TBL] [Abstract][Full Text] [Related]
19. Response to steroid and immunosuppressive therapies may predict post-transplant recurrence of steroid-resistant nephrotic syndrome.
Miura K; Ando T; Kanda S; Hashimoto T; Kaneko N; Ishizuka K; Hamada R; Hataya H; Hotta K; Gotoh Y; Nishiyama K; Hamasaki Y; Shishido S; Fujita N; Hattori M
Pediatr Transplant; 2022 Dec; 26(8):e14103. PubMed ID: 34309142
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of podocyte genes in children with sporadic steroid-resistant nephrotic syndrome.
Feng DN; Yang YH; Wang DJ; Meng DC; Fu R; Wang JJ; Yu ZH
Genet Mol Res; 2014 Nov; 13(4):9514-22. PubMed ID: 25501161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
